Navigation Links
Frost & Sullivan Cites Arm & Hammer for Excellence in the Dairy Animal Nutrition and Management Market
Date:9/8/2009

nt rumen management and proper nutrition. In lactating rations, FERMENTEN improves feed efficiency (more milk producer per pound of feed consumed) and reduces the amount of additional protein in the ration, resulting in a better bottom line for producers. A consistent, palatable anion source, BIO-CHLOR(R) delivers a negative DCAD precalving, which helps ward off metabolic disorders and increase milk production in the subsequent lactation. MEGALAC(R)-R improves reproductive success while decreasing incidence of costly postcalving metabolic disorders, thereby facilitating producer's long-term profitability. DCAD Plus(R) and sodium bicarbonate (buffers) boost milk and component production, mitigate the effects of heat stress and increase income generation for dairy producers. Milk protein is the most lucrative part of a milk check; MEGALAC PLUS(TM) provides extra energy and rumen-inert methionine for synthesizing milk protein in high-producing cows.

"Further, feeding Arm & Hammer Animal Nutrition products aid in efficient feed utilization, indirectly reducing the carbon footprint of the dairy and nitrogen emissions, as increases in milk production can be attained without an increase in feed inputs," notes Pasricha. "Such environmental benefits reiterate the leading edge demonstrated by Arm & Hammer Animal Nutrition over its competitors."

Arm & Hammer Animal Nutrition products excel in guaranteeing safe and reliable use. Its manufacturing plants have continually received certifications from the American Feed Industry Association (AFIA) Safe Feed/Safe Food program and the Facility Certification Institute (FCI). In addition, Arm & Hammer Animal Nutrition uses no animal byproducts and the ingredients are traceable throughout the manufacturing process. Dairy producers prefer feed ingredients that are research-proven. The superior benefits delivered by high-quality Arm & Hammer Animal Nutrition products are valida
'/>"/>

SOURCE Frost & Sullivan
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Frost & Sullivan Global Heart Health Ingredients Excellence in Financial & Risk Management Award Conferred on Pronova BioPharma
2. Aging Population, Heightened Consumer Awareness Propel U.S. Bone and Joint Health Ingredients, Says Frost & Sullivan
3. Added Investment Into Healthcare By the Government Drives Growth in the European Hospital Information Systems Market, Notes Frost & Sullivan
4. U.S. Compression Therapy Market to Reach $1.16 Billion in 2015, Finds Frost & Sullivan
5. Frost & Sullivan Recognizes Carestream Health with the 2009 Latin American Computed Radiology Customer Value Leadership Award
6. Mennen Medical Receives Frost & Sullivan 2009 European Patient Monitoring Technology Leadership Award
7. Frost & Sullivan: Growing Healthcare Tourism in Malaysia
8. A Wound that Does Not Heal: Frost & Sullivan Reveals the Impact of Chronic Ulcers on the European Healthcare System
9. Frost & Sullivan: Malaysia Diagnostics and Devices Industry Outlook 2009
10. Frost & Sullivan: Medico Legal Implications Related to the Usage of Electronic Health Record
11. Smart Payment Strategies Enable Growth in Home Health Care and Disease Management Markets for Remote Patient Monitoring, Finds Frost & Sullivan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... and environmental concerns about the emerging nanotechnology industry, scientists ... of nanoparticles in municipal sewage treatment plants their ... in ACS, journal Environmental Science & Technology . ... and Hydrology and colleagues note that experts predict large ... than 1/1000th the width of a human hair ...
(Date:12/16/2009)... they cut bleeding time in half, but use in humans ... -- Hoping to improve on nature, researchers have built and ... be used in trauma or other cases where blood just ... with material that is used in degradable stitches, which dissolve ... biomedical engineering at Case Western Reserve University, and lead author ...
(Date:12/16/2009)... for use, expert says, , , WEDNESDAY, Dec. 16 (HealthDay ... less likely to die when they receive an implantable ... included 4,685 people, ages 65 to 85, who were ... fraction (a measure of the heart,s pumping ability) of ... those who were treated with standard medication and an ...
(Date:12/16/2009)... -- Medical travel facilitator Companion Global Healthcare Inc. ... into its network of international hospitals that treat ... at mainland U.S. facilities. ,, The announcement means ... and preferred pricing for its individual clients and ... HIMA San Pablo Bayamon or HIMA San Pablo ...
(Date:12/16/2009)... 16 Quantros, Inc., a leading provider ... solutions for the healthcare industry, announces the creation ... has named software industry veteran Michael Tulloch, MBA, ... work from the company,s new Marlborough, MA office. ... natural one," explains Tulloch. "Quantros has been developing ...
Breaking Medicine News(10 mins):Health News:Behavior modification could ease concerns about nanoparticles 2Health News:Synthetic Platelets Put the Brakes on Blood Loss 2Health News:Synthetic Platelets Put the Brakes on Blood Loss 3Health News:Implanted Defibrillator Might Extend Life 2Health News:Hospitals in Puerto Rico Join Companion Global Healthcare's Network 2Health News:Safety and Quality Software Developer Quantros, Inc. Launches Healthcare IT Consulting Division 2
... cancer death rate in African Americans has continued to decrease ... in African American men and 18// percent higher in African ... most recent time period (2003). ,However, the ... because rates have decreased faster in African Americans than whites. ...
... has been a marked increase in allergic reactions among people ... a 30 year period.// Teenagers appear to be more susceptible, ... with a trend. ,The common allergic reactions are ... may be required. ,Now researchers are pressing for ...
... exhausted, people should take these complaints seriously// before they ... says a University of Alberta researcher investigating fatigue. ... from the Faculty of Nursing, argues that there are ... those distinctions will help health-care workers create better treatment ...
... clinical practice guidelines for diagnosis and management of venous ... causes clotting in the veins. ,Key elements ... prediction rules to establish pretest probability of deep vein ... testing and the utility of various diagnostic tools such ...
... is a condition resulting from inflammation of joints. ... movement.// ,Spondylarthritis (SpA), ankylosing spondylitis (AS), ... all associated rheumatic diseases collectively known as "spondyloarthropathies".,Aside ... by ankylosis, stiffness and fusion of bone in ...
... vaccines, announced today that it has developed a promising ... Francisella tularensis is a bacterium considered to be one ... ,This vaccine project was funded by a BioDefense ... Institute of Allergy and Infectious Diseases (NIAID), a division ...
Other Medicine News:Health News:Cancer Death Rates High in African-Americans 2Health News:Take Fatigue Seriously - Says Researcher 2Health News:Take Fatigue Seriously - Says Researcher 3Health News:New Guidelines for Diagnosis of Venous Thromboembolism 2Health News:Does Anti-TNF Therapy Control Ankylosis ? 2Health News:Rhode Island Biotechnology Company Develops Tularemia Vaccine 2
(Date:12/16/2009)... 16 BioSpecifics Technologies Corp. (Nasdaq: ... class collagenase-based products, today announced top-line efficacy and ... of XIAFLEX(TM) for the treatment of Peyronie,s disease. ... inelastic collagen on the shaft of the penis, ... intercourse difficult or impossible in advanced cases. The ...
(Date:12/16/2009)... -- Vivakor, Inc. (OTC Bulletin Board: VIVK) ... Baker Consulting out of Walnut Creek, California ... out of South Florida. Baker Consulting ... with business development, financing and assisting the ... Specifically, Baker Consulting is exploring potential acquisition ...
(Date:12/16/2009)... Naurex Inc., a new clinical stage company developing ... based on its novel GFPA NMDA receptor modulators, ... I clinical trial of its lead compound GLYX-13 ... the study. GLYX-13, a glycine site functional ... receptor, is initially being developed as a therapy ...
Breaking Medicine Technology:BioSpecifics Technologies Corp. Announces Top-Line Phase 2b Results for XIAFLEX(TM) for Treatment of Peyronie's Disease 2BioSpecifics Technologies Corp. Announces Top-Line Phase 2b Results for XIAFLEX(TM) for Treatment of Peyronie's Disease 3BioSpecifics Technologies Corp. Announces Top-Line Phase 2b Results for XIAFLEX(TM) for Treatment of Peyronie's Disease 4Vivakor Signs Business Development Agreement With Baker Consulting 2Naurex Inc. Initiates Phase I Clinical Trial of its Novel Mechanism NMDA Modulator GLYX-13 in Treatment-Resistant Depression 2Naurex Inc. Initiates Phase I Clinical Trial of its Novel Mechanism NMDA Modulator GLYX-13 in Treatment-Resistant Depression 3UPMC and UPMC Health Plan Recognized by National Business Group on Health As a Leading Employer Promoting Healthy Lifestyles for Its Employees 50065 1UPMC and UPMC Health Plan Recognized by National Business Group on Health As a Leading Employer Promoting Healthy Lifestyles for Its Employees 50065 2UPMC and UPMC Health Plan Recognized by National Business Group on Health As a Leading Employer Promoting Healthy Lifestyles for Its Employees 50065 3Elsevier Releases Results of Alternative Energy Research Leadership Study Identifying Top 25 Institutions Worldwide 12788 1Elsevier Releases Results of Alternative Energy Research Leadership Study Identifying Top 25 Institutions Worldwide 12788 2Elsevier Releases Results of Alternative Energy Research Leadership Study Identifying Top 25 Institutions Worldwide 12788 3Elsevier Releases Results of Alternative Energy Research Leadership Study Identifying Top 25 Institutions Worldwide 12788 4Elsevier Releases Results of Alternative Energy Research Leadership Study Identifying Top 25 Institutions Worldwide 12788 5Elsevier Releases Results of Alternative Energy Research Leadership Study Identifying Top 25 Institutions Worldwide 12788 6Elsevier Releases Results of Alternative Energy Research Leadership Study Identifying Top 25 Institutions Worldwide 12788 7Respiratory Rally a Promising Practice in the Fight Against Chronic Disease 50062 1Respiratory Rally a Promising Practice in the Fight Against Chronic Disease 50062 2
... in brain,research and technology may have a great impact ... scientists visiting the US Senate today. At the,invitation of ... researchers from Posit Science, a leading provider of cognitive,training ... and,part hands-on science fair., "Many believe that we ...
... ... Meeting, WELLESLEY HILLS, Mass., ... of Spherics, Inc. ("Spherics") for,the benefit of creditors, announced today that all ... on October 10,2008., Topamax(R) produces adverse effects on cognitive functions at ...
Other Medicine Technology:Senate Told Brain Technology Can Impact Public Policy 2Senate Told Brain Technology Can Impact Public Policy 3Spherics, Inc. Announces Reduced Cognitive Impairment of Novel Extended Release Topiramate (SRx-502) as Compared to Topamax(R) 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: